Buscar
-
Time to define common European criteria for therapeutic added value
(Thérapie, 2021-04-24)Article de revue -
Tranexamic Acid for the Prevention of Blood Loss after Cesarean Delivery
(New England Journal of Medicine. vol. 384, n° 17, pp. 1623-1634, 2021-04-29)Article de revue -
Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA-FLUO Trial
(Movement Disorders, 2021-04-01)Article de revue -
Aspergillose bronchopulmonaire allergique (ABPA) et mucoviscidose : mécanismes, diagnostic et alternatives thérapeutiques
(Revue des Maladies Respiratoires. vol. 38, n° 5, pp. 466-476, 2021-05)Article de revue -
Risk of severe clinical events after sustained virological response following direct-acting antiviral therapy in HIV and hepatitis C virus coinfected participants
(HIV Medicine, 2021-07-01)Article de revue -
Multidrug-resistant tuberculosis imported into low-incidence countries-a GeoSentinel analysis, 2008-2020
(Journal of Travel Medicine, 2021-05-12)Article de revue -
Effects of a Mindfulness-Based Intervention versus Health Self-Management on Subclinical Anxiety in Older Adults with Subjective Cognitive Decline: The SCD-Well Randomized Superiority Trial
(Psychotherapy and Psychosomatics. pp. 1-10, 2021-04-19)Article de revueLibre acceso -
Use of IV Iron and Risk of Anaphylaxis: A Multinational Observational Post-Authorisation Safety Study in Europe
(Pharmacoepidemiology and Drug Safety, 2021-06-28)Article de revueLibre acceso -
Looking for somatic mutations in UBA1 in patients with chronic myelomonocytic leukemia associated with systemic inflammation and autoimmune diseases
(Leukemia & lymphoma. pp. 1-3, 2021-09-03)Article de revue -
Trends of Antibacterial Resistance at the National Reference Laboratory in Cameroon: Comparison of the Situation between 2010 and 2017
(BioMed Research International. vol. 2021, pp. 9957112, 2021-05-24)Article de revueLibre acceso